About: Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Antonio Fernandez-Nebro et al published May 2005 in American Journal of Medicine

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2005 (fr) наукова стаття, опублікована в травні 2005 (uk) im Mai 2005 veröffentlichter wissenschaftlicher Artikel (de) article by Antonio Fernandez-Nebro et al published May 2005 in American Journal of Medicine (en)
publication date	wds:Q56564660-2962E8F8-F9D2-49A3-AEDA-DAACE5E90E15
publication date	2005-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56564660-4D2B3B2F-DED0-48E4-8861-72E830B73E0A
language of work or name	English
author name string	wds:Q56564660-054F4024-F333-4B4F-8A76-8ED9A4206D1E wds:Q56564660-08542675-B2B4-4866-89E4-4E9707B11B36 wds:Q56564660-2D0FE4B6-ED3D-46EE-8EAE-19B0B614F5AA wds:Q56564660-B1DFDB2A-8E06-4F2D-B1C8-7C5B3B74D86B wds:Q56564660-B35F3386-1C59-44CA-8DE7-BF7D5B29FF29 wds:Q56564660-CE087043-8B5C-4E3F-9B72-B334CC689F05 wds:Q56564660-D4BCFEFF-B7D9-4FF4-808E-172CF51DB97D wds:Q56564660-EE624B10-F147-4F4F-B0AB-3395398B3B63
author name string	Alejandro Olivé Eva Tomero Armando Laffón Manuel de Haro María Carmen Castro María Victoria González-Mari Rosa García-Vicuña Rosario García-Vicuña
rdfs:label	Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists (en) Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists (nl)
skos:prefLabel	Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists (en) Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists (nl)
name	Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists (en) Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists (nl)
author	wds:Q56564660-09D7FA23-BD0A-41FF-817E-52DDFE958DE5 wds:Q56564660-8B18A5B1-E4AF-4831-959F-0464A48D65B4
author	Antonio Fernandez-Nebro Vera Ortiz-Santamaría
title	wds:Q56564660-2D2AAE6E-6896-406A-94C9-F74229A73801
title	Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists (en)
page(s)	wds:Q56564660-AD94E82C-775F-4989-8066-42FA33C8886B
page(s)	552-556
instance of	wds:Q56564660-9FF5FA4B-6FF6-4A2E-9C20-FB2D906A6D31
instance of	scholarly article
main subject	wds:Q56564660-E0EDD6A8-D4AC-4FFB-8C2F-B15BAA670A75
main subject	inflammation
PubMed ID	wds:Q56564660-28A3A99A-3F5B-4C5B-ABFA-61AFB9BF67B2
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15866260
PubMed ID	15866260
published in	wds:Q56564660-F95ED20C-00D6-4C20-890E-217BA2C2E7FA
published in	American Journal of Medicine
issue	wds:Q56564660-014EB558-607B-493F-A4E6-C7EF2BBBBF10
volume	wds:Q56564660-8FCDB7A6-385C-44C4-88EE-12E2A335AB5D
issue	5
volume	118
DOI	wds:Q56564660-0794CE7D-7949-4123-A08A-EDB5422AFD7E
DOI	http://dx.doi.org/10.1016/J.AMJMED.2005.01.028
DOI	10.1016/J.AMJMED.2005.01.028
ResearchGate publication ID	wds:Q56564660-75CFABC9-7F6F-4652-9A0E-8B31D97AF891
ResearchGate publication ID	7872459
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56564660
is cites work of	Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis Cognitive improvement with intrathecal administration of infliximab in a woman with Alzheimer's disease. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007 Successful use of Tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice Amyloidosis is frequently undetected in patients with rheumatoid arthritis Ankylosing spondylitis-related secondary amyloidosis responded well to etanercept: a report of three patients Paraplegia, proteinuria, and renal failure Infliximab as a treatment for systemic amyloidosis associated with Crohn's disease Effect of etanercept on serum amyloid A protein (SAA) levels in patients with AA amyloidosis complicating inflammatory arthritis Systemic AA amyloidosis: epidemiology, diagnosis, and management Turkish experience in rheumatoid arthritis patients with clinical apparent amyloid deposition. The efficacy and safety of etanercept in patients with rheumatoid arthritis and spondyloarthropathy on hemodialysis Anti-TNF-alpha for treatment of amyloidosis associated with Crohn's disease Gastric outlet obstruction due to gastric amyloidosis mimicking malignancy in a patient with ankylosing spondylitis wd:Q95359600 Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis. Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease. A case with rheumatoid arthritis and systemic reactive AA amyloidosis showing rapid regression of amyloid deposition on gastroduodenal mucosa after a combined therapy of corticosteroid and etanercept wd:Q95359592 Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease. Renal manifestations in rheumatic diseases Treatment of chronic inflammatory diseases with biologic agents: opportunities and risks for the elderly [Renal amyloidosis complicating adult onset Still's disease: about three cases]
is cites work of	wds:Q38219934-1F2993B1-4708-4C6F-810C-29421492A0FF wds:Q42835576-9AAA65C3-64B2-494C-B582-14762441C52E wds:Q49917457-F83FFC1C-2718-45AA-AE22-0D537AB7095D wds:Q58125125-DD544B09-E041-493F-950A-CEF13DFA903C wds:Q84700987-C43FE0B0-51FE-439C-9EE2-081BCFC7C9DC wds:Q95359592-3EC9C4BA-71CC-468E-AFD1-B9AB6D3760BF wds:Q42836064-79713403-A7CB-45A3-8BBC-DD5BBE59E096 wds:Q50154733-74FAE727-299C-4931-B0D6-0D4DC2146562 wds:Q95359600-7E3A1D45-1B2E-47BD-AF51-16B7D218681C wds:Q46671479-7F5E6AED-4A2E-4801-92D2-C756609F729C wds:Q34637889-1A020E3B-2952-42E1-B821-4DEE4F6B19B1 wds:Q36663141-9F37313C-B2DB-4928-A5D8-7654B682F044 wds:Q42844805-5D2660BF-B64C-434D-BB10-53C908CAF739 wds:Q80568974-FD8501F6-D335-4C4A-8BBF-3E2949FCCBAD wds:Q84207053-3320164F-95D3-4406-AD7D-333E83B5B35E wds:Q36171750-B507F2B9-3ACA-45C4-8B46-797A705906EB

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software